Well my understanding is that the present ART (antiretroviral therapy) drugs are exceptional at keeping the viral load down to about zero, the problem being the hidden viruses in the reservoirs that emerge when the ART drugs are removed. So I have been paying some attention. BIT225 will have to address this problem IMO to be of interest to anyone. Note a phase 3 trial is very expensive to do.
- Forums
- ASX - By Stock
- BIT
- COVID19 - competitive landscape
COVID19 - competitive landscape, page-192
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $25.26M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $2.114K | 75.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 87026 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 45600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 87026 | 0.028 |
1 | 45000 | 0.027 |
5 | 289518 | 0.026 |
5 | 268646 | 0.025 |
3 | 299000 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 45600 | 1 |
0.030 | 60000 | 2 |
0.031 | 179129 | 4 |
0.032 | 500000 | 1 |
0.039 | 257353 | 1 |
Last trade - 15.45pm 04/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |